Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 179,759 | 256,572 | 165,753 | 150,327 | 83,288 |
| Marketable Securities | 373,414 | 346,818 | 387,129 | 400,857 | 439,502 |
| Receivables | 16,689 | 14,675 | 15,914 | 13,775 | 12,260 |
| Inventories | 7,632 | 6,521 | 7,313 | 6,616 | 7,409 |
| TOTAL | $586,777 | $631,093 | $582,827 | $579,079 | $549,798 |
| Non-Current Assets | |||||
| PPE Net | 10,080 | 10,602 | 11,106 | 11,513 | 11,720 |
| Intangibles | 149,920 | 153,321 | 148,435 | 149,612 | 150,887 |
| Other Non-Current Assets | 32,717 | 33,389 | 34,265 | 34,871 | 34,361 |
| TOTAL | $192,717 | $197,312 | $193,806 | $195,996 | $196,968 |
| Total Assets | $779,494 | $828,405 | $776,633 | $775,075 | $746,766 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,848 | 18,434 | 15,144 | 5,830 | 8,343 |
| Accrued Expenses | 82,694 | 69,240 | 75,180 | 63,308 | 62,465 |
| Other current liabilities | 13,324 | 13,556 | 13,588 | 27,956 | 26,169 |
| TOTAL | $124,492 | $119,473 | $124,088 | $113,163 | $96,977 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,503 | 14,229 | 16,268 | 16,069 | N/A |
| Other Non-Current Liabilities | 482,054 | 481,122 | 330,054 | 330,458 | 317,486 |
| TOTAL | $498,289 | $500,791 | $350,433 | $354,542 | $317,486 |
| Total Liabilities | $622,781 | $620,264 | $474,521 | $467,705 | $414,463 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,958 | 63,514 | 63,212 | 61,226 | 60,717 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -878,744 | -811,712 | -765,966 | -714,393 | -678,754 |
| Other shareholders' equity | -1,082 | -1,695 | -562 | -525 | -641 |
| TOTAL | $156,713 | $208,141 | $302,112 | $307,370 | $332,303 |
| Total Liabilities And Equity | $779,494 | $828,405 | $776,633 | $775,075 | $746,766 |